Lv3
310 积分 2023-05-19 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1天前
待确认
STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications
1天前
已完结
Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
7天前
已完结
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
8天前
已完结
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
10天前
已完结
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
11天前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
15天前
已完结
Key links in the physiological regulation of the immune system and disease induction: T cell receptor -CD3 complex
15天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
21天前
已完结
EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review
25天前
已完结
皖公网安备34019202002308
